BR0011028A - Agentes anestésicos dérmicos - Google Patents

Agentes anestésicos dérmicos

Info

Publication number
BR0011028A
BR0011028A BR0011028-0A BR0011028A BR0011028A BR 0011028 A BR0011028 A BR 0011028A BR 0011028 A BR0011028 A BR 0011028A BR 0011028 A BR0011028 A BR 0011028A
Authority
BR
Brazil
Prior art keywords
compounds
anesthetic agents
dermal
aminoindan
dermal anesthetic
Prior art date
Application number
BR0011028-0A
Other languages
English (en)
Portuguese (pt)
Inventor
A K Gunnar Aberg
George L Wright
Jan L Chen
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of BR0011028A publication Critical patent/BR0011028A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0011028-0A 1999-06-10 2000-06-06 Agentes anestésicos dérmicos BR0011028A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13835399P 1999-06-10 1999-06-10
US17926700P 2000-01-31 2000-01-31
PCT/US2000/015490 WO2000076510A1 (en) 1999-06-10 2000-06-06 Dermal anesthetic agents

Publications (1)

Publication Number Publication Date
BR0011028A true BR0011028A (pt) 2002-02-19

Family

ID=26836123

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011028-0A BR0011028A (pt) 1999-06-10 2000-06-06 Agentes anestésicos dérmicos

Country Status (18)

Country Link
US (1) US6413987B1 (OSRAM)
EP (1) EP1185267B1 (OSRAM)
JP (1) JP2003501469A (OSRAM)
CN (1) CN1355700A (OSRAM)
AT (1) ATE335482T1 (OSRAM)
AU (1) AU777517B2 (OSRAM)
BR (1) BR0011028A (OSRAM)
CA (1) CA2376819C (OSRAM)
CY (1) CY1105721T1 (OSRAM)
DE (1) DE60029954T2 (OSRAM)
DK (1) DK1185267T3 (OSRAM)
ES (1) ES2267546T3 (OSRAM)
IL (2) IL146190A0 (OSRAM)
MX (1) MXPA01012632A (OSRAM)
NO (1) NO323856B1 (OSRAM)
NZ (1) NZ515143A (OSRAM)
PT (1) PT1185267E (OSRAM)
WO (1) WO2000076510A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1321139T1 (sl) * 2001-12-21 2007-02-28 Chiesi Farma Spa 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine
PL376890A1 (pl) * 2002-11-26 2006-01-09 Maruishi Pharmaceutical Co., Ltd. Pochodne izoindoliny
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US20090137628A1 (en) * 2005-09-23 2009-05-28 Bridge Pharma, Inc. Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain
US20110218218A1 (en) * 2005-09-23 2011-09-08 Bridge Pharma, Inc. Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
DK2244737T3 (da) * 2008-01-22 2019-07-08 Univ Texas Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
BR112013020874A2 (pt) * 2011-02-18 2019-05-21 Endo Pharmaceuticals Inc. composto, regime, método para a preparação do referido composto, e, uso de um composto
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
US8685418B2 (en) 2011-10-24 2014-04-01 Endo Pharmaceuticals Inc. Cyclohexylamines
US9044482B2 (en) 2012-08-15 2015-06-02 Asana Biosciences, Llc Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
EA201891225A1 (ru) 2015-11-23 2018-11-30 Грейс Терапьютикс Ллк Пленкообразующий спрей для местного применения
JP7656266B2 (ja) 2018-12-19 2025-04-03 グレイス セラピューティクス、インコーポレイテッド 鼻腔内リドカインの治療用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760018A (fr) * 1969-12-19 1971-06-08 Christiaens Sa A Nouveau derives du 2-amino-indane, leur preparation et leur utilisation
US3923813A (en) 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
AR206505A1 (es) * 1972-09-18 1976-07-30 Christiaens Sa A Procedimiento para obtener nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano
ZA738419B (en) 1972-11-06 1974-09-25 Christiaens Sa A New derivatives of 2-aminoindane,the preparation and use thereof
GB1462036A (en) * 1973-02-05 1977-01-19 Manuf Prod Pharma Aminoindane derivatives
GB1468347A (en) * 1973-03-02 1977-03-23 Christiaens Sa A Aminoindanes

Also Published As

Publication number Publication date
MXPA01012632A (es) 2004-03-19
US6413987B1 (en) 2002-07-02
CN1355700A (zh) 2002-06-26
CA2376819A1 (en) 2000-12-21
NO20016037D0 (no) 2001-12-10
CA2376819C (en) 2008-09-02
DK1185267T3 (da) 2006-12-11
EP1185267A4 (en) 2003-09-03
WO2000076510A9 (en) 2002-07-04
CY1105721T1 (el) 2010-12-22
JP2003501469A (ja) 2003-01-14
WO2000076510A1 (en) 2000-12-21
DE60029954T2 (de) 2007-03-08
DE60029954D1 (de) 2006-09-21
EP1185267A1 (en) 2002-03-13
EP1185267B1 (en) 2006-08-09
IL146190A0 (en) 2002-07-25
AU5596300A (en) 2001-01-02
NZ515143A (en) 2004-05-28
ES2267546T3 (es) 2007-03-16
NO323856B1 (no) 2007-07-16
AU777517B2 (en) 2004-10-21
IL146190A (en) 2008-11-03
PT1185267E (pt) 2006-12-29
ATE335482T1 (de) 2006-09-15
NO20016037L (no) 2002-02-11

Similar Documents

Publication Publication Date Title
BR0011028A (pt) Agentes anestésicos dérmicos
BR9810712A (pt) Processo para a prevenção ou tratamento de prurido em um paciente
TR200102800T2 (tr) Yeni bileşikler.
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
BR0017026A (pt) Lipeptìdeos como agentes antibacterianos
BR9707958A (pt) Composto, composição farmacêutica, e, processo para tratar hiperalgesia em um paciente.
BR0014060A (pt) Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
BRPI0109200B8 (pt) compostos e composições farmacêuticas
BR9802029A (pt) Composição, processo para aperfeiçoar a repelência à água e a durabilidadeem composições de fibra, de não-tecido, de têxtil e de papel, e, artigo.
BR0116402A (pt) Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
BR9912138A (pt) Compostos cìclicos úteis no tratamento de dislipidemia, aterosclerose e diabetes, composções farmacêuticas e processo para preparação
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
BR0110430A (pt) Processo para a preparação de um composto, composto, e, uso do mesmo
IT1302264B1 (it) Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi
ES2165029T3 (es) Hidrofluoruros de amina y su utilizacion como agentes para la higiene bucal.
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
BR0014461A (pt) Composto e método para preparar o mesmo
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
BRPI0410512A (pt) processo que compreende o contato de po3g e composição que compreende (i) po3g
PT1204659E (pt) Benzofuranos serotoninergicos

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]